Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jerald Radich
Adherence to BCR-ABL Inhibitors: Issues for CML Therapy
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Related publications
Maintaining Low BCR-ABL Signaling Output to Restrict CML Progression and Enable Persistence
Current Hematologic Malignancy Reports
Cancer Research
Oncology
Hematology
Broad Spectrum Alkynyl Inhibitors of T315I BCR-Abl
Bioorganic and Medicinal Chemistry Letters
Organic Chemistry
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Drug Discovery
Inhibition of the BCR-Abl Tyrosine Kinase as a Therapeutic Strategy for CML
Oncogene
Cancer Research
Genetics
Molecular Biology
Intracellular Retention of ABL Kinase Inhibitors Determines Commitment to Apoptosis in CML Cells
PLoS ONE
Multidisciplinary
Tyrosine Kinase Inhibitors in BCR-ABL Positive Acute Lymphoblastic Leukemia
Haematologica
Hematology
A Multiple Reaction Monitoring (MRM) Method to Detect BCR-Abl Kinase Activity in CML Using a Peptide Biosensor
PLoS ONE
Multidisciplinary
Past, Present, and Future of BCR-Abl Inhibitors: From Chemical Development to Clinical Efficacy
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Coexistence of AML1/RUNX1 and BCR-ABL Point Mutations in an Imatinib-Resistant Form of CML
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
BCR-ABL Tyrosine Kinase
Science-Business eXchange